Hyacinth Thomas
Nurse Practitioner · Lawrenceville, GANPI 1164402343
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 24.2% of the total. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 389 payments — averaging $48.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$5K
- Sanofi-aventis U.S. LLC$4K
- Novo Nordisk$2K
- Xeris Pharmaceuticals, Inc.$1K
- Amgen$729
- Lilly USA, LLC$679
- plus $6K from 41 others
What the payments were for
- Consulting fees$1,6329%
- Speaking & faculty fees$6,39834%
- Travel & lodging$390%
- Food & beverage$10,82657%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$4,264
- TZIELD$1,303
- GVOKE PFS$626
- RYBELSUS$467
- Ozempic$448
- iLet Bionic Pancreas$383
- MINIMED 780G$289
- GVOKE HYPOPEN$233
- DEXCOM G7 GSS (161)$140
- EVENITY$129
- TUKYSA$125
- Kerendia$123
- INPEN SMART INSULIN DELIVERY SYSTEM$122
- Saxenda$120
- FARXIGA$119
- INGREZZA$114
- Wegovy$109
- AUSTEDO$107
- TWIIST$104
How this compares
$18,907 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 409 | $503,919 |
| MounjaroTirzepatide | 178 | $221,910 |
| JardianceEmpagliflozin | 159 | $169,615 |
| TrulicityDulaglutide | 133 | $160,486 |
| FarxigaDapagliflozin Propanediol | 177 | $156,829 |
| Tresiba Flextouch U-200Insulin Degludec | 70 | $71,619 |
| Tresiba Flextouch U-100Insulin Degludec | 95 | $66,274 |
| Humalog Kwikpen U-200Insulin Lispro | 30 | $65,071 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 40 | $62,399 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 52 | $49,460 |
| RybelsusSemaglutide | 20 | $30,841 |
| Novolog FlexpenInsulin Aspart | 121 | $27,483 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 13 | $24,333 |
| NovologInsulin Aspart | 52 | $22,284 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $19,719 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $1,951 | $557,044481 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $679 | $395,642360 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr | $198 | $194,046197 claims |
| AstraZenecaFarxiga | $266 | $156,829177 claims |
| MerckJanumet, Januvia | $55 | $34,70956 claims |
| BayerKerendia | $281 | $11,02315 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $3,973 | $8,59633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Lawrenceville
- Tracy PerryLawrenceville$14K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
- Luis PoloSavannah$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.